Objectives This study sought to investigate the incidence and identify the predictors of significant tricuspid regurgitation (TR) development long after left-sided valve surgery.
Tricuspid regurgitation (TR) is a common finding in patients undergoing mitral or combined mitral/aortic valve surgery. 1, 2 Although TR may decrease gradually after left-sided valve surgery owing to reduced right ventricular pressure or volume overload, 3 TR does not always regress after adequate correction of the underlying lesions 4, 5 and often progresses some time after surgery without leftsided valvular dysfunction, even after tricuspid annuloplasty. Furthermore, TR can appear de novo during postoperative follow-up. Because it is well known that TR progression badly affects long-term mortality and morbidity, and that surgical correction of TR after left-sided valve surgery is associated with disappointingly high mortality and morbidity, [6] [7] [8] [9] the prevention of late TR is clinically important. In this regard, information regarding the incidence and predictors of progression or development of late TR is of substantial value for determining optimal operative timing and the surgical strategy to prevent late TR development, at the time of surgery for underlying left-sided valve disease. Several previous reports on this topic have been limited by a relatively small study population, 5 ,10 a short-term follow-up, 11 or the lack of reliable echocardiographic data. 12 Therefore, the present study was performed to investigate the incidence of late de novo TR development after left-sided valve surgery and to identify preoperative predictors in patients without significant preoperative TR by long-term clinical and echocardiographic follow-up.
Methods

Study population
This study was based on our consecutive experiences of patients who underwent surgical correction for left-sided valve disease from January 1992 to December 1995. During this period, a total of 615 patients underwent surgery for mitral, aortic, or combined mitral/aortic valve disease at our institution, and these were initially considered eligible for this study. However, we excluded patients who underwent combined tricuspid valve replacement (n = 19), aortic surgery (n = 20), correction of combined congenital anomaly (n = 31), and coronary artery bypass graft surgery (n = 22). Seventy-four patients who were lost to follow-up, 40 patients who died within 5 years of index surgery, and 74 patients with significant preoperative TR, moderate or severe in degree, were also excluded. Accordingly, 335 patients (159 male, 47.5%) who completed at least a 5-year clinical and echocardiographic follow-up were enrolled.
Baseline data procurement
Patient hospital records and our cardiac surgery database were reviewed for the following: age at index surgery, sex, body weight, height, heart rhythm, type of surgery, and history of prior cardiac surgery. Preoperative cardiac catheterization was performed in all patients, and parameters including pulmonary capillary wedge pressure, systolic pulmonary artery pressure, and mean right atrial pressure were measured. A preoperative echocardiographic examination was performed in all patients by a skilled echocardiographer and interpreted by an experienced cardiologist. Left ventricular end-systolic and end-diastolic diameters, left ventricular ejection fraction, left atrial dimension, and valvular functions were comprehensively evaluated. Etiologies of valvular disease were confirmed based on surgical observations and/or pathologic findings. The study protocol was approved by the Institutional Review Board of Seoul National University Hospital.
Echocardiographic examinations
Comprehensive 2-dimensional and Doppler echocardiographic examinations were performed preoperatively and repeated after discharge from hospital by skilled echocardiographers in a standard manner using commercially available echocardiographic devices. The presence of TR and its severity were assessed using multiple transthoracic windows. The maximal TR jet area in any echocardiographic view was used to semi-quantitatively estimate TR grade using a standard color Doppler technique. Tricuspid regurgitation grade was classified as none, trace, mild, moderate, or severe in each patient. 13, 14 To simplify statistical analysis, significant TR was defined as moderate or severe in degree. Maximal TR jet velocity was obtained by continuous-wave Doppler and was used to calculate systolic pulmonary artery pressure. Latest echocardiographic examinations were regarded as the end of the follow-up period.
Statistical analysis
Continuous variables are expressed as means ± SD, and categorical variables as percentages. Multiple logistic regression analysis using the forward stepwise selection process, including all significant parameters identified by univariate analysis and previously known confounding variables, was undertaken to identify parameters independently associated with the presence of significant TR after surgery. Event-free cumulative survival rates were plotted using the Kaplan-Meier method and comparisons were made between patient groups with and without late significant TR using the log-rank test. SPSS 13.0 (SPSS Inc, Chicago, IL) was used for the statistical analyses and P values of b.05 were considered statistically significant.
Results
Baseline characteristics
The baseline characteristics of the 335 study subjects are summarized in Table I . Mean follow-up duration was 11.6 ± 2.1 years (range 5.1-14.6 years). Preoperative electrocardiograms showed atrial fibrillation in 189 (56.4%) of the patients.
Mitral valve surgery (mitral valve replacement or mitral valve repair) without accompanying aortic valve surgery was performed in 174 patients (51.9%), aortic valve surgery alone (aortic valve replacement or aortic valve repair) in 74 (22.1%), and combined mitral and aortic valve surgery in the remaining 87 (26.0%). At the time of left-sided valve surgery, tricuspid annuloplasty was performed in 15 patients (4.5%).
Preoperative diagnoses according to valve disease and the procedures performed to correct underlying valve abnormalities are detailed in Tables II and III, respectively. Of 261 patients who underwent mitral valve surgery with or without an aortic valve operation, mitral valve diseases were caused by rheumatic disease in 138 (52.9%), 
Development of late significant TR
The development of late significant TR in all study subjects and patients according to cardiac rhythm is shown in Figure 1 . Significant TR had developed in 90 patients (26.9%) at last follow-ups, and this was severe in 25 (7.5%).
Clinical and echocardiographic characteristics according to the presence or absence of late TR are summarized in Table IV . Patients who developed late TR were older (47.6 ± 13.4 vs 44.3 ± 13.2 years, P = .04), had a higher prevalence of preoperative atrial fibrillation (83.3% vs 46.5%, χ 2 = 36.3, P b .001), a greater left atrial dimension (56.9 ± 12.3 vs 52.4 ± 11.5 mm, P = .006), a lower left ventricular end-diastolic dimension (54.6 ± 11.1 vs 58.4 ± 12.0 mm, P = .01), and were more likely to have undergone prior valve surgery (44.0% vs 25.3%, χ 2 = 6.9, P = .009). Of note, late TR was observed more frequently in patients with mitral valve surgery (93.3% vs 72.2%, χ 2 = 17.0, P b .001). However, other factors, such as etiologies, left ventricular ejection fraction, systolic pulmonary artery pressure, pulmonary capillary wedge pressure, and mean right atrial pressure, were comparable in the 2 study groups.
Independent determinants of late TR
To identify independent clinical and echocardiographic factors for the development of late TR, we performed multivariate forward conditional logistic regression analysis using clinical, echocardiographic, and cardiac catheterization parameters, that is, age, sex, history of previous valve surgery, performance of mitral valve surgery, presence of preoperative atrial fibrillation, left atrial size, left ventricular end-diastolic dimension, preoperative systolic pulmonary artery pressure, and presence of preoperative mild TR. This analysis identified the presence of preoperative atrial fibrillation (odds ratio 5.37, 95% CI 2.71-10.65, P b .001) as the only independent determinant of the development of late TR.
Clinical events during follow-up
Of the 335 study subjects, 62 patients succumbed away during follow-up. Causes of death were heart failure in 9, cerebrovascular events in 13, myocardial infarction in 5, endocarditis in 12, malignancy in 5, unexpected Development of significant TR during follow-up after left-sided valve surgery in all study subjects, and in patients according to cardiac rhythm. Af, Atrial fibrillation. accidents in 2, liver disease in 5, sepsis in 2, other causes including sudden death in 3, and unknown in 6. During the same period, reoperation for isolated severe TR was performed in 12 patients, among whom 2 died from right ventricular failure. When cardiovascular death and reoperation were defined as clinical events, the probability of event-free survival rate in patients without late TR was 97.0% ± 1.1% at 100 months, 87.7% ± 2.8% at 140 months, 85.9% ± 2.6% at 160 months, and 85.9% ± 2.6% at 175 months. By comparison, the probability of event-free survival rate in patients with late TR was 94.4% ± 2.4% at 100 months, 86.2% ± 3.7% at 140 months, 70.9% ± 5.9% at 160 months, and 62.0% ± 9.8% at 175 months. Thus, patients with late TR showed significantly lower event-free survival rates during followup (P = .03) (Figure 2 ).
Discussion
In the present study, it was found that the incidence of late TR was 26.9% after left-sided valve surgery in patients without preoperative significant TR, and that the incidence of severe TR was 7.5%. Multivariate logistic regression analysis revealed the presence of preoperative atrial fibrillation as the only independent predictor of late TR development, with an approximately 5-fold elevated risk. Furthermore, late TR was found to be accompanied by a lower long-term event-free survival rate. To the best of our knowledge, this is the largest study to have evaluated TR late after left-sided valve surgery with a longterm echocardiographic follow-up.
Clinical significance of late TR
The development of late TR is a common and important manifestation after left-sided valve surgery and is known to be linked to exercise intolerance and a poor prognosis. 6, 15, 16 In particular, moderate and severe TR are closely coupled with a poor prognosis, even in the absence of the left ventricular dysfunction or pulmonary hypertension. 15 The reported incidences of TR late after left-sided valve surgery vary from 16% to 67%, according to study population, the definition of significant TR, and follow-up duration. 5, [10] [11] [12] Tricuspid regurgitation incidence was found to be 16% by Matsuyama et al 11 , but the follow-up duration was relatively short (mean 8.2 years). In contrast, Porter et al 5 reported a much higher incidence of 67% after a mean follow-up of ca 11 years, but the study population was relatively small. In the present study, the incidence of late TR development was found to be ca 27% with a mean follow-up of 11.6 years, and late TR was found to be closely associated with poor event-free survival. In our opinion, a follow-up duration of N10 years is required to detect patients who develop clinically significant TR late after left-sided valve surgery and to elucidate its prognostic implications. This is supported by the results shown in Figure 2 , where the discrepancy in event-free cumulative survival rates was progressively widened 10 years after left-sided valve surgery.
Mechanism of late TR
Although the underlying mechanism of late TR after valve surgery is substantially unknown, it is generally considered "functional" in nature, because the tricuspid valve is morphologically normal in most patients. However, in contrast to the wealth of information available regarding functional mitral regurgitation, little is available on the mechanism of functional TR. In a previous study, we demonstrated that right ventricular geometry and tricuspid annular dilation are closely associated with functional TR development and severity. 10, 17, 18 This issue requires further investigation.
Prevention of late TR development
In view of the clinical significance of TR, the identification of predictors of late TR is clinically important. Previous studies have shown that the presence of preoperative significant TR, the presence of preoperative atrial fibrillation, an advanced age, or huge left atrium is an independent predictor of late TR development. 5, 11, 12 In the present study, we only recruited patients without significant preoperative TR to emphasize the de novo development of significant TR and to remove potential by residual TR after left-sided valve surgery. As a result, it was found that only 1 clinical factor, the presence of preoperative atrial fibrillation, contributed independently to the occurrence of late TR by multivariate analysis.
As corrective surgery for late TR is associated with high operative mortality and morbidity, 8, 9, 19 its prevention has clinically important implications. Currently, tricuspid annuloplasty is widely performed as a safe and effective Comparison of event-free cumulative survival rates according to the presence or absence of late significant tricuspid regurgitation.
surgical tool for reducing tricuspid annular dimension, but no generally accepted indications for tricuspid annuloplasty have been established. Although preoperative TR severity and tricuspid annular dimension usually serve as a guide as to whether tricuspid valve annuloplasty is indicated, 20 tricuspid annuloplasty is adamantly unsuccessful in a substantial number of patients. 21 Our findings as is do not provide mechanistic insights into the determinants of late TR. The association with atrial fibrillation may be due to the fact that atrial fibrillation reflects a more advanced underlying valve disease. However, based on the previous observations on the impact of chronic atrial fibrillation, [22] [23] [24] it is likely that chronic atrial fibrillation induces atrial remodeling and tricuspid annular dilation which, in turn, develops late TR. Therefore, it is suggested that tricuspid annuloplasty should be considered even in patients without significant TR in the presence of preoperative atrial fibrillation. In addition, a combined maze operation on top of tricuspid annuloplasty may provide a solution to the problem. Previously, we demonstrated that the maze operation can effectively prevent TR development due to the restoration and maintenance of atrial mechanical activity. 25 More importantly, careful monitoring for the development of atrial fibrillation and the timely surgical correction of underlying left-sided valve disease may help prevent significant TR development late after surgery and possibly improve long-term prognosis.
Limitations
Several limitations of the present study need to be acknowledged. First, this study is limited by its retrospective nature. However, the preoperative, operative, and postoperative findings were prospectively summarized in our database system, which was specifically designed and maintained throughout the study period. Second, TR grade was not quantified, but although quantification may have provided an objective means of evaluating TR, semi-quantitative TR evaluations were well validated with angiographic evaluation and clinical measures of regurgitant severity and thus are widely used in practice. 13, 14 Finally, because we excluded 40 patients who died within 5 years of surgery to focus on the late development of TR, the event-free survival rates of our study population were artificially elevated and do not represent the true postoperative event-free survival.
Conclusions
The de novo development of significant TR long after left-sided valve surgery is not uncommon, with an estimated incidence of 27%, and is closely associated with a poor prognosis. The present study identified preoperative atrial fibrillation as the only independent predictor for the development of late TR. Therefore, tricuspid annuloplasty should be considered in the presence of atrial fibrillation, even in patients' mild TR at the time of surgical correction for left-sided valve disease.
